Covered recipient · General Payments record
CASSANDRA E HADDAD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,365.45
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.62 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $324.56 | 14 |
| EISAI INC. | $33.71 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.14 | 1 |
| Antares Pharma, Inc. | $20.06 | 1 |
| Novo Nordisk AS | $18.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.00 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270231 | CMS |
| ABBVIE INC. | $22.24 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270233 | CMS |
| ABBVIE INC. | $12.97 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270235 | CMS |
| ABBVIE INC. | $15.97 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270237 | CMS |
| ABBVIE INC. | $7.32 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270239 | CMS |
| ABBVIE INC. | $12.66 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270241 | CMS |
| ABBVIE INC. | $11.61 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270243 | CMS |
| ABBVIE INC. | $16.02 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270245 | CMS |
| ABBVIE INC. | $118.07 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270247 | CMS |
| ABBVIE INC. | $32.08 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270249 | CMS |
| ABBVIE INC. | $14.36 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270251 | CMS |
| ABBVIE INC. | $3.91 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270253 | CMS |
| ABBVIE INC. | $12.04 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270255 | CMS |
| ABBVIE INC. | $15.31 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107270257 | CMS |
| Alexion Pharmaceuticals, Inc. | $20.14 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093951680 | CMS |
| Antares Pharma, Inc. | $20.06 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146507047 | CMS |
| Eisai Inc. | $33.71 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110796855 | CMS |
| Novo Nordisk Inc | $18.15 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100581988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.